Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PYRAZINAMIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 170 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Somoskovi, A; Parsons, LM; Salfinger, M
      The molecular basis of resistance to isoniazid, rifampin, and pyrazinamidein Mycobacterium tuberculosis

      RESPIRATORY RESEARCH
    2. Lavini, V; Maia, AD; Paulino, IS; Schuchardt, U; de Oliveira, W
      Synthesis, characterization and catalytic activity of some organolanthanides in ethylene polymerization

      INORGANIC CHEMISTRY COMMUNICATIONS
    3. Gennaro, MC; Calvino, R; Abrigo, C
      Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids

      JOURNAL OF CHROMATOGRAPHY B
    4. Berning, SE; Cherry, TA; Iseman, MD
      Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: Case report

      CLINICAL INFECTIOUS DISEASES
    5. Sackoff, JE; Torian, LV; Frieden, TR
      TB prevention in HIV clinics in New York City

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    6. van Loenhout-Rooyackers, JH; Keyser, A; Laheij, RJF; Verbeek, ALM; van der Meer, JWM
      Tuberculous meningitis: is a 6-month treatment regimen sufficient?

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    7. Bishop, KS; Blumberg, L; Trollip, AP; Smith, AN; Roux, L; York, DF; Kiepiela, P
      Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    8. Lee, KW; Lee, JM; Jung, KS
      Characterization of pncA mutations of pyrazinamide-resistant Mycobacteriumtuberculosis in Korea

      JOURNAL OF KOREAN MEDICAL SCIENCE
    9. Gillespie, SH
      Antibiotic resistance in the absence of selective pressure

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    10. Shibata, K; Fukuwatari, T; Sugimoto, E
      Effects of dietary pyrazinamide, an antituberculosis agent, on the metabolism of tryptophan to niacin and of tryptophan to serotonin in rats

      BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    11. Antonucci, G; Girardi, E; Raviglione, M; Vanacore, P; Angarano, G; Chirianni, A; Pagano, G; Suter, F; Lauria, FN; Ippolito, G
      Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study

      EUROPEAN RESPIRATORY JOURNAL
    12. Singh, S; Mariappan, TT; Sankar, R; Sarda, N; Singh, B
      A critical review of the probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    13. Shishoo, CJ; Shah, SA; Rathod, IS; Savale, SS; Vora, MJ
      Impaired bioavailability of rifampicin in presence of isoniazid from fixeddose combination (FDC) formulation

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    14. Sun, ZH; Cheng, SJ; Zhang, H; Zhang, Y
      Salicylate uniquely induces a 27-kDa protein in tubercle bacillus

      FEMS MICROBIOLOGY LETTERS
    15. Sakamoto, N; Yamamoto, T; Moriwaki, Y; Teranishi, T; Toyoda, M; Onishi, Y; Kuroda, S; Sakaguchi, K; Fujisawa, T; Maeda, M; Hada, T
      Identification of a new point mutation in the human xanthine dehydrogenasegene responsible for a case of classical type I xanthinuria

      HUMAN GENETICS
    16. Johnson, JL; Okwera, A; Hom, DL; Mayanja, H; Kityo, CM; Nsubuga, P; Nakibali, JG; Loughlin, AM; Yun, H; Mugyenyi, PN; Vernon, A; Mugerwa, RD; Ellner, JJ; Whalen, CC
      Duration of efficacy of treatment of latent tuberculosis infection in HIV infected adults

      AIDS
    17. Lemaitre, N; Callebaut, I; Frenois, F; Jarlier, V; Sougakoff, W
      Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis

      BIOCHEMICAL JOURNAL
    18. Begley, TP; Kinsland, C; Mehl, RA; Osterman, A; Dorrestein, P
      The biosynthesis of nicotinamide adenine dinucleotides in bacteria

      VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 61
    19. Blomberg, B; Spinaci, S; Fourie, B; Laing, R
      The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis

      BULLETIN OF THE WORLD HEALTH ORGANIZATION
    20. Wallis, RS; Palaci, M; Vinhas, S; Hise, AG; Ribeiro, FC; Landen, K; Cheon, SH; Song, HY; Phillips, M; Dietze, R; Ellner, JJ
      A whole blood bactericidal assay for tuberculosis

      JOURNAL OF INFECTIOUS DISEASES
    21. Berning, SE
      The role of fluoroquinolones in tuberculosis today

      DRUGS
    22. Yamamoto, T; Moriwaki, Y; Shibutani, Y; Matsui, K; Ueo, T; Takahashi, S; Tsutsumi, Z; Hada, T
      Human xanthine dehydrogenase cDNA sequence and protein in an atypical caseof type I xanthinuria in comparison with normal subjects

      CLINICA CHIMICA ACTA
    23. Lomillo, MAA; Renedo, OD; Martinez, MJA
      Resolution of ternary mixtures of rifampicin, isoniazid and pyrazinamide by differential pulse polarography and partial least squares method

      ANALYTICA CHIMICA ACTA
    24. Espinosa-Mansilla, A; Valenzuela, MIA; de la Pena, AM; Salinas, F; Canada, FC
      Comparative study of partial least squares and a modification of hybrid linear analysis calibration in the simultaneous spectrophotometric determination of rifampicin, pyrazinamide and isoniazid

      ANALYTICA CHIMICA ACTA
    25. Wang, Y; Li, YS; Wu, J; Zhang, ZX; An, DQ
      Surface-enhanced Raman spectra of some anti-tubercle bacillus drugs

      SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
    26. Daniel, N; Lounis, N; Ji, BH; O'Brien, RJ; Vernon, A; Geiter, LJ; Szpytma, M; Truffot-Pernot, C; Hejblum, G; Grosset, J
      Antituberculosis activity of once-weekly rifapentine-containing regimens in mice - Long-term effectiveness with 6-and 8-month treatment regimens

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    27. Mitchison, DA
      Role of individual drugs in the chemotherapy of tuberculosis

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    28. Heifets, L; Higgins, M; Simon, B
      Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    29. Ohno, M; Yamaguchi, I; Yamamoto, I; Fukuda, T; Yokota, S; Maekura, R; Ito, M; Yamamoto, Y; Ogura, T; Maeda, K; Komuta, K; Igarashi, T; Azuma, J
      Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid andrifampicin-induced hepatotoxicity

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    30. Chaisson, RE
      New developments in the treatment of latent tuberculosis

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    31. Hou, L; Osei-Hyiaman, D; Zhang, Z; Wang, B; Yang, A; Kano, K
      Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China

      EPIDEMIOLOGY AND INFECTION
    32. Spaia, S; Magoula, I; Tsapas, G; Vayonas, G
      Effect of pyrazinamide and probenecid on peritoneal urate transport kinetics during continuous ambulatory peritoneal dialysis

      PERITONEAL DIALYSIS INTERNATIONAL
    33. Suzuki, K; Tsuyuguchi, K; Matsumoto, H; Niimi, A; Tanaka, E; Amitani, R
      Effect of proton pump inhibitor alone or in combination with clarithromycin on mycobacterial growth in human alveolar macrophages

      FEMS MICROBIOLOGY LETTERS
    34. Saito, K; Fujigaki, S; Heyes, MP; Shibata, K; Takemura, M; Fujii, H; Wada, H; Noma, A; Seishima, M
      Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    35. Wong, WM; Wu, PC; Yuen, MF; Cheng, CC; Yew, WW; Wong, PC; Tam, CM; Leung, CC; Lai, CL
      Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

      HEPATOLOGY
    36. Niemann, S; Harmsen, D; Rusch-Gerdes, S; Richter, E
      Differentiation of clinical Mycobacterium tuberculosis complex isolates bygyrB DNA sequence polymorphism analysis

      JOURNAL OF CLINICAL MICROBIOLOGY
    37. Liu, YP; Behr, MA; Small, PM; Kurn, N
      Genotypic determination of Mycobacterium tuberculosis antibiotic resistance using a novel mutation detection method, the branch migration inhibition M-tuberculosis antibiotic resistance test

      JOURNAL OF CLINICAL MICROBIOLOGY
    38. Conte, JE; Golden, JA; McQuitty, M; Kipps, J; Lin, ET; Zurlinden, E
      Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    39. Martin-Casabona, N; Alcaide, F; Coll, P; Gonzalez, J; Manterola, JM; Salvado, M; Cayla, JA
      Drug resistance of Mycobacterium tuberculosis. Multicenter study in Barcelona, Spain

      MEDICINA CLINICA
    40. Brown, TJ; Tansel, O; French, GL
      Simultaneous identification and typing of multi-drug-resistant Mycobacterium tuberculosis isolates by analysis of pncA and rpoB

      JOURNAL OF MEDICAL MICROBIOLOGY
    41. Conte, JE; Lin, E; Zurlinden, E
      Liquid chromatographic determination of rifampin in human plasma, bronchoalveolar lavage fluid, and alveolar cells

      JOURNAL OF CHROMATOGRAPHIC SCIENCE
    42. Boshoff, HIM; Mizrahi, V
      Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides

      JOURNAL OF BACTERIOLOGY
    43. Guo, M; Sun, ZH; Zhang, Y
      Mycobacterium smegmatis has two pyrazinamidase enzymes, PncA and PzaA

      JOURNAL OF BACTERIOLOGY
    44. Shibutani, Y; Ueo, T; Takahashi, S; Moriwaki, Y; Yamamoto, T
      Effect of ACTH on renal excretion of purine bases in a patient with isolated ACTH deficiency

      CLINICA CHIMICA ACTA
    45. Barry, CE; Slayden, RA; Sampson, AE; Lee, RE
      Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs

      BIOCHEMICAL PHARMACOLOGY
    46. Corrigan, D; Paton, J
      Hepatic enzyme abnormalities in children on triple therapy for tuberculosis

      PEDIATRIC PULMONOLOGY
    47. Raynaud, C; Laneelle, MA; Senaratne, RH; Draper, P; Laneelle, G; Daffe, M
      Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity

      MICROBIOLOGY-UK
    48. Peloquin, CA; Namdar, R; Dodge, AA; Nix, DE
      Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    49. Gangadharam, PRJ; Geeta, N; Hsu, YY; Wise, DL
      Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    50. Roy, V; Tekur, U; Chopra, K
      Pharmacokinetics of pyrazinamide in children suffering from pulmonary tuberculosis

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    51. Sbarbaro, J; Blomberg, B; Chaulet, P
      Fixed-dose combination formulations for tuberculosis treatment

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    52. Ellard, GA
      The evaluation of rifampicin bioavailabilities of fixed-dose combinations of anti-tuberculosis drugs: procedures for ensuring laboratory proficiency

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    53. Smith, PJ; van Dyk, J; Fredericks, A
      Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    54. McIlleron, H; Gabriels, G; Smith, PJ; Fourie, PB; Ellard, GA
      The development of a standardised screening protocol for the in vivo assessment of rifampicin bioavailability

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    55. Ellard, GA
      The colorimetric analysis of anti-tuberculosis fixed-dose combination tablets and capsules

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    56. Fourie, PB
      Proposed minimum registration requirements for fixed-dose combination anti-tuberculosis drugs

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    57. Blomberg, B; Kitler, ME; Milstien, J; Dellepiane, N; Fanning, A; Norval, PY; Spinaci, S
      Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization's vaccine model?

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    58. Miniyar, PB; Bhat, AR
      Pyrazinoic acid hydrazide derivatives: Synthesis and antimycobacterial activities

      INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY
    59. Migliori, GB; Raviglione, MC; Schaberg, T; Davies, PDO; Zellweger, JP; Grzemska, M; Mihaescu, T; Clancy, L; Casali, L
      Tuberculosis management in Europe

      EUROPEAN RESPIRATORY JOURNAL
    60. Goicoechea, HC; Olivieri, AC
      Simultaneous determination of rifampicin, isoniazid and pyrazinamide in tablet preparations by multivariate spectrophotometric calibration

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    61. Kelly, JJ; Horowitz, EA; Destache, CJ; Fruin, AH; Long, VA
      Diagnosis and treatment of complicated tubercular meningitis

      PHARMACOTHERAPY
    62. Bell, JC; Rose, DN; Sacks, HS
      Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective

      AIDS
    63. Hirano, K; Abe, C; Takahashi, M
      Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay

      JOURNAL OF CLINICAL MICROBIOLOGY
    64. Troesch, A; Nguyen, H; Miyada, CG; Desvarenne, S; Gingeras, TR; Kaplan, PM; Cros, P; Mabilat, C
      Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays

      JOURNAL OF CLINICAL MICROBIOLOGY
    65. DeRiemer, K; Daley, CL; Reingold, AL
      Preventing tuberculosis among HIV-infected persons: A survey of physicians' knowledge and practices

      PREVENTIVE MEDICINE
    66. Miyazaki, E; Chaisson, RE; Bishai, WR
      Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    67. Wallis, RS; Patil, S; Cheon, SH; Edmonds, K; Phillips, M; Perkins, MD; Joloba, M; Namale, A; Johnson, JL; Teixeira, L; Dietze, R; Siddiqi, S; Mugerwa, RD; Eisenach, K; Ellner, JJ
      Drug tolerance in Mycobacterium tuberculosis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    68. Peloquin, CA; Namdar, R; Singleton, MD; Nix, DE
      Pharmacokinetics of rifampin under fasting conditions, with food, and withantacids

      CHEST
    69. Shibutani, Y; Ueo, T; Yamamoto, T; Takahashi, S; Moriwaki, Y; Higashino, K
      A case of classical xanthinuria (type 1) with diabetes mellitus and Hashimoto's thyroiditis

      CLINICA CHIMICA ACTA
    70. Maranetra, KN
      Quinolones and multidrug-resistant tuberculosis

      CHEMOTHERAPY
    71. KRAEMER HJ; FELTKAMP U; BREITHAUPT H
      QUANTIFICATION OF PYRAZINAMIDE AND ITS METABOLITES IN PLASMA BY IONIC-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - IMPLICATIONS FOR THE SEPARATION MECHANISM

      Journal of chromatography B. Biomedical sciences and applications
    72. ALLEN LV; ERICKSON MA
      STABILITY OF BETHANECHOL CHLORIDE, PYRAZINAMIDE, QUINIDINE SULFATE, RIFAMPIN, AND TETRACYCLINE HYDROCHLORIDE IN EXTEMPORANEOUSLY COMPOUNDEDORAL LIQUIDS

      American journal of health-system pharmacy
    73. UNGO JR; JONES D; ASHKIN D; HOLLENDER ES; BERNSTEIN D; ALBANESE AP; PITCHENIK AE
      ANTITUBERCULOSIS DRUG-INDUCED HEPATOTOXICITY - THE ROLE OF HEPATITIS-C VIRUS AND THE HUMAN-IMMUNODEFICIENCY-VIRUS

      American journal of respiratory and critical care medicine
    74. KOUMBANIOU C; NICOPOULOS C; VASSILIOU M; MANDASTACHOULI C; SAKELLARIOU K; DEMOU GS; CONSTANTOPOULOS SH
      IS PYRAZINAMIDE REALLY THE 3RD DRUG OF CHOICE IN THE TREATMENT OF TUBERCULOSIS

      The international journal of tuberculosis and lung disease
    75. OLIVIER C; RADAL M; MAZAUD S; JONVILLEBERA AP; MARTEL C; AUTRET E
      RASH ASSOCIATED WITH FIRST DOSE OF ANTITU BERCULOSIS POLYTHERAPY - RESPONSIBILITY OF PYRAZINAMIDE

      Archives de pediatrie
    76. RADAL M; JONVILLEBERA AP; VANEGROO C; CARRE P; LEMARIE E; AUTRET E
      RASHES AFTER PYRAZINAMIDE TREATMENT

      Revue des maladies respiratoires
    77. Walubo, A; Smith, P; Folb, PI
      The role of oxygen free radicals in isoniazid-induced hepatotoxicity

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    78. VANLOENHOUTROOYACKERS JH; VEEN J
      TREATMENT OF PULMONARY TUBERCULOSIS

      Netherlands journal of medicine
    79. YEW WW
      THERAPEUTIC DRUG-MONITORING IN ANTITUBERCULOSIS CHEMOTHERAPY

      Therapeutic drug monitoring
    80. CYNAMON MH; SPEIRS RJ; WELCH JT
      IN-VITRO ANTIMYCOBACTERIAL ACTIVITY OF 5-CHLOROPYRAZINAMIDE

      Antimicrobial agents and chemotherapy
    81. TELENTI A
      GENETICS OF DRUG-RESISTANT TUBERCULOSIS

      Thorax
    82. ORMEROD P; CAMPBELL I; NOVELLI V; POZNIAK A; DAVIES P; SKINNER C; MOOREGILLON J; DARBYSHIRE J; DROBNIEWSKI F
      CHEMOTHERAPY AND MANAGEMENT OF TUBERCULOSIS IN THE UNITED-KINGDOM - RECOMMENDATIONS 1998

      Thorax
    83. HARRIES AD; NYANGULU DS; KANGOMBE C; NDALAMA D; GLYNN JR; BANDA H; WIRIMA JJ; SALANIPONI FM; LIOMBA G; MAHER D; NUNN P
      TREATMENT OUTCOME OF AN UNSELECTED COHORT OF TUBERCULOSIS PATIENTS INRELATION TO HUMAN-IMMUNODEFICIENCY-VIRUS SEROSTATUS IN ZOMBA HOSPITAL, MALAWI

      Transactions of the Royal Society of Tropical Medicine and Hygiene
    84. YAMAMOTO T; MORIWAKI Y; TAKAHASHI S; TSUTSUMI Z; OHATA H; FUJITA T; YAMAKITA J; NAKANO T; HIROISHI K; HIGASHINO K
      EFFECT OF BUCLADESINE SODIUM ON THE PLASMA-CONCENTRATIONS AND URINARY-EXCRETION OF PURINE-BASES AND URIDINE

      Metabolism, clinical and experimental
    85. WACHTER GA; DAVIS MC; MARTIN AR; FRANZBLAU SG
      ANTIMYCOBACTERIAL ACTIVITY OF SUBSTITUTED ISOSTERES OF PYRIDINECARBOXYLIC AND PYRAZINECARBOXYLIC ACIDS

      Journal of medicinal chemistry
    86. WALLIS RS; PERKINS M; PHILLIPS M; JOLOBA M; DEMCHUK B; NAMALE A; JOHNSON JL; WILLIAMS D; WOLSKI K; TEIXEIRA L; DIETZE R; MUGERWA RD; EISENACH K; ELLNER JJ
      INDUCTION OF THE ANTIGEN-85 COMPLEX OF MYCOBACTERIUM-TUBERCULOSIS IN SPUTUM - A DETERMINANT OF OUTCOME IN PULMONARY TUBERCULOSIS TREATMENT

      The Journal of infectious diseases
    87. SHIN M; IWAMOTO N; YAMASHITA M; SANO K; UMEZAWA C
      PYRIDINE NUCLEOTIDE LEVELS IN LIVER OF RATS FED CLOFIBRATE-CONTAININGOR PYRAZINAMIDE-CONTAINING DIETS

      Biochemical pharmacology
    88. Espinosa-Mansilla, A; Valenzuela, MA; Salinas, F; Canada, EC
      Kinetic determination of ansamicins in pharmaceutical formulations and human urine. Manual and semiautomatic (stopped-flow) procedures

      ANALYTICA CHIMICA ACTA
    89. MEHMEDAGIC A; VERITE P; MENAGER S; THARASSE C; CHABENAT C; ANDRE D; LAFONT O
      DETERMINATION OF PYRAZINAMIDE AND ITS MAIN METABOLITES IN RAT URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    90. SUN ZH; SCORPIO A; ZHANG Y
      THE PNCA GENE FROM NATURALLY PYRAZINAMIDE-RESISTANT MYCOBACTERIUM-AVIUM ENCODES PYRAZINAMIDASE AND CONFERS PYRAZINAMIDE SUSCEPTIBILITY TO RESISTANT MYCOBACTERIUM-TUBERCULOSIS COMPLEX ORGANISMS

      Microbiology
    91. MITCHISON DA; STRUM AW
      THE MEASUREMENT OF EARLY BACTERICIDAL ACTIVITY

      Bailliere's clinical infectious diseases
    92. CHOUDHRI SH; HAWKEN M; GATHUA S; MINYIRI GO; WATKINS W; SAHAI J; SITAR DS; AOKI FY; LONG R
      PHARMACOKINETICS OF ANTIMYCOBACTERIAL DRUGS IN PATIENTS WITH TUBERCULOSIS, AIDS, AND DIARRHEA

      Clinical infectious diseases
    93. SHUTER J; BELLIN E
      MULTIDRUG-RESISTANT TUBERCULOSIS

      Infectious diseases in clinical practice
    94. PAGE DL; PIZZICONI VB
      A CELL-BASED IMMUNOBIOSENSOR WITH ENGINEERED MOLECULAR RECOGNITION .2. ENZYME AMPLIFICATION SYSTEMS

      Biosensors & bioelectronics
    95. HEYM B; COLE ST
      MULTIDRUG-RESISTANCE IN MYCOBACTERIUM-TUBERCULOSIS

      International journal of antimicrobial agents
    96. SHIBATA K; ISHIKAWA A; KONDO T
      EFFECTS OF DIETARY PYRAZINAMIDE ON THE METABOLISM OF TRYPTOPHAN TO NIACIN IN STREPTOZOTOCIN-DIABETIC RATS

      Bioscience, biotechnology, and biochemistry
    97. BEEKMANN SE; DOEBBELING BN
      FRONTIERS OF OCCUPATIONAL-HEALTH - NEW VACCINES, NEW PROPHYLACTIC REGIMENS, AND MANAGEMENT OF THE HIV-INFECTED WORKER

      Infectious disease clinics of North America
    98. SANCHEZALBISUA I; VIDAL ML; JOYAVERDE G; DELCASTILLO F; DEJOSE MI; GARCIAHORTELANO J
      TOLERANCE OF PYRAZINAMIDE IN SHORT-COURSE CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS IN CHILDREN

      The Pediatric infectious disease journal
    99. JOUVESHOMME S; DAUTZENBERG B
      ANTITUBERCULOUS CHEMOTHERAPY

      Revue des maladies respiratoires
    100. BISHAI WR; CHAISSON RE
      SHORT-COURSE CHEMOPROPHYLAXIS FOR TUBERCULOSIS

      Clinics in chest medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 09:50:00